Status:
NOT_YET_RECRUITING
Under-Represented Communities Diagnosed With SCD or MCI Through Tele-Cog
Lead Sponsor:
Ohio State University
Conditions:
Mild Cognitive Impairment
Subjective Cognitive Decline
Eligibility:
All Genders
50+ years
Brief Summary
Overall, this study's primary aim is to establish a prospective, longitudinal, observational cohort study of older adults at risk for dementia from under-resourced/underrepresented communities. More s...
Detailed Description
Clinical data obtained as part of standard of care will be collected from the medical record (including clinical diagnosis, cognitive and other neuropsychological test scores, lab results, neuroimagin...
Eligibility Criteria
Inclusion
- Adults ages 50 years and older
- Diagnosed with subjective cognitive concerns (SCD) or objective cognitive decline with mostly intact functioning (MCI diagnosis) as part of clinical work up
- Fluent in English
- Able to provide voluntary informed consent
- Willing and able to undergo all study procedures
- Able to delegate, if possible, a study partner to contribute information regarding daily activities and cognition
Exclusion
- Diagnosis of dementia at baseline.
- Inability to give informed consent.
- High risk of adverse emotional or behavioral reaction based on investigator's clinical evaluation (e.g., evidence of serious personality disorder, antisocial behavior, serious current stressors, lack of meaningful social support).
Key Trial Info
Start Date :
August 1 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 1 2032
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT06542458
Start Date
August 1 2025
End Date
January 1 2032
Last Update
July 30 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Ohio State University
Columbus, Ohio, United States, 43210